Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119731 | Modus Therapeutics Holding AB (MODTX TR.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119732 | Pila Pharma AB (PILA BTA.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 0.34 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119733 | Spago Nanomedical AB (publ) (SPAGO BTU.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 0.62 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119734 | Amniotics AB (publ) (AMNI TO 3.ST) | FNSE | SE | 2022-12-31 | 1 month ago | SEK | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119735 | Acarix AB (ACARIX TO2.ST) | FNSE | SE | 2022-12-31 | 1 month ago | SEK | 0.00 | 0.00 | 0.00% | 0.13 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119736 | Modus Therapeutics Holding AB (MODTX BTA.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119737 | Diamyd Medical AB (DMYD TO 3 B.ST) | FNSE | SE | 2023-08-31 | 1 week ago | SEK | 0.00 | 0.00 | 0.00% | 1.22 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119738 | Acousort AB (ACOU BTU.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 1.18 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119739 | Cyxone AB (CYXO BTA.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 0.25 | 0.00% | Ungraded | 0.00 | 0.00% |
| 119740 | Cell Impact AB (publ) (CI UR.ST) | FNSE | SE | 2022-12-31 | 4 months ago | SEK | 0.00 | 0.00 | 0.00% | 2.12 | 0.00% | Ungraded | 0.00 | 0.00% |